ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 726332 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 726332; 2) Community: the network communities that were significantly associated with the response to NSC 726332; 3) Molecule: the relationships between components within communities and NSC 726332; 4) MDR: the compounds that were significantly associated with the NSC 726332.

NSC Compound Enrichment Correlation
NSC 7390 Null 0.03551961774939 0.1537376
NSC 740520 6-(3-Bromopropyl)-9-fluoro-5,6-dihydro-2,3-dimethoxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.03551961774939 0.68717052
NSC 740524 6-(3-Azidopropyl)-9-fluoro-5,6-dihydro-2,3-dimethoxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.03551961774939 0.7417662
NSC 740975 6-(3-Chloropropyl)-9-cyano-5,6-dihydro-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.03551961774939 0.65609187
NSC 743884 Null 0.03551961774939 0.40228992
NSC 750501 1,5-bis[4-(N-butylamidino)phenoxy]-3-tiapentane dihydrochloride 0.03551961774939 -0.050268089
NSC 757925 3,5-bis(4-hydroxy-3-methoxystyryl)-N-(4-fluorophenyl)-1H-pyrazole-1-carboxamide 0.03551961774939 0.37011525
NSC 85235 10.alpha.H-Ambrosa-2,11(13)-dien-12-oic acid, 6.beta.-hydroxy-4-oxo-, .gamma.-lactone (8CI) 0.03551961774939 0.21066953
NSC 93354 Null 0.03551961774939 0.30710129
NSC 174121 Methotrexate Derivative 0.0361455178924431 0.50807994
Total:67  Current:51    [First] [Prev] [Next] [Last]